IT1155241B - Preparato farmaceutico contenente un sale di deferossammina per il trattamento di malattia di alzheimer - Google Patents

Preparato farmaceutico contenente un sale di deferossammina per il trattamento di malattia di alzheimer

Info

Publication number
IT1155241B
IT1155241B IT49698/82A IT4969882A IT1155241B IT 1155241 B IT1155241 B IT 1155241B IT 49698/82 A IT49698/82 A IT 49698/82A IT 4969882 A IT4969882 A IT 4969882A IT 1155241 B IT1155241 B IT 1155241B
Authority
IT
Italy
Prior art keywords
deferossamine
salt
treatment
pharmaceutical preparation
preparation containing
Prior art date
Application number
IT49698/82A
Other languages
English (en)
Other versions
IT8249698A0 (it
Inventor
Donald Raymond Mclachlan
Original Assignee
Donald Raymond Mclachlan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Donald Raymond Mclachlan filed Critical Donald Raymond Mclachlan
Publication of IT8249698A0 publication Critical patent/IT8249698A0/it
Application granted granted Critical
Publication of IT1155241B publication Critical patent/IT1155241B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT49698/82A 1981-12-21 1982-12-20 Preparato farmaceutico contenente un sale di deferossammina per il trattamento di malattia di alzheimer IT1155241B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/332,794 US4419365A (en) 1981-12-21 1981-12-21 Method of treating Alzheimer's disease

Publications (2)

Publication Number Publication Date
IT8249698A0 IT8249698A0 (it) 1982-12-20
IT1155241B true IT1155241B (it) 1987-01-21

Family

ID=54774394

Family Applications (1)

Application Number Title Priority Date Filing Date
IT49698/82A IT1155241B (it) 1981-12-21 1982-12-20 Preparato farmaceutico contenente un sale di deferossammina per il trattamento di malattia di alzheimer

Country Status (6)

Country Link
US (1) US4419365A (it)
JP (1) JPS58121213A (it)
BE (1) BE895406A (it)
DE (1) DE3247062A1 (it)
IT (1) IT1155241B (it)
ZA (1) ZA829335B (it)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE34313E (en) * 1983-09-23 1993-07-13 National Research Development Corporation Pharmaceutical compositions
US4912118A (en) * 1983-09-23 1990-03-27 National Research Development Corporation Pharmaceutical compositions
US5177068A (en) * 1984-04-19 1993-01-05 National Research Development Corporation Pharmaceutical compositions
ATE55375T1 (de) * 1984-12-19 1990-08-15 Ciba Geigy Ag Neue kohlensaeureester.
US5217998A (en) * 1985-07-02 1993-06-08 Biomedical Frontiers, Inc. Composition for the stabilization of deferoxamine to chelate free ions in physiological fluid
EP0214101A3 (de) * 1985-09-03 1989-05-31 Ciba-Geigy Ag Verwendung von Eisen(III)-Chelatoren vom Typ Desferrioxamin B und Desferriferrithiocin zur Behandlung von Malaria
US4599361A (en) * 1985-09-10 1986-07-08 G. D. Searle & Co. Hydroxamic acid based collagenase inhibitors
US4743587A (en) * 1985-09-10 1988-05-10 G. D. Searle & Co. Hydroxamic acid based collagenase inhibitors
US4698431A (en) * 1985-11-12 1987-10-06 The United States Of America As Represented By The United States Department Of Energy Hydroxypyridonate chelating agents
US5707604A (en) * 1986-11-18 1998-01-13 Access Pharmaceuticals, Inc. Vivo agents comprising metal-ion chelates with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles
US5672334A (en) * 1991-01-16 1997-09-30 Access Pharmaceuticals, Inc. Invivo agents comprising cationic metal chelators with acidic saccharides and glycosaminoglycans
MX12394A (es) * 1987-07-23 1993-12-01 Ciba Geigy Ag Procedimiento par la obtencion de carbamatos de polietilenglicol.
US4897388A (en) * 1988-12-20 1990-01-30 Geriatric Research Institute, Inc. Method of treating Alzheimer's disease
US5023784A (en) * 1989-04-06 1991-06-11 Doral Technical Services, Inc. Method for diagnosing serum deficiencies
US5158979A (en) * 1989-04-19 1992-10-27 New York University Method and compositions for treating pneumocystic carini infections
US5268165A (en) * 1990-10-16 1993-12-07 Biomedical Frontiers, Inc. Polymer-deferoxamine-ferric iron adducts for use in magnetic resonance imaging
WO1993010459A1 (en) * 1991-11-12 1993-05-27 The University Of Melbourne A method for assaying and treating alzheimer's disease
HU214452B (hu) * 1992-06-01 1998-03-30 BIOGAL Gyógyszergyár Rt. Eljárás nagytisztaságú deferoxamin-B-sók előállítására
GB9211779D0 (en) * 1992-06-03 1992-07-15 Ciba Geigy Ag Amine salts
TW274630B (it) * 1994-01-28 1996-04-21 Wako Zunyaku Kogyo Kk
JPH0925234A (ja) * 1995-07-12 1997-01-28 Wakunaga Pharmaceut Co Ltd 脳疾患改善剤
US6106866A (en) * 1995-07-31 2000-08-22 Access Pharmaceuticals, Inc. In vivo agents comprising cationic drugs, peptides and metal chelators with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles, including tumor sites
US20030236224A1 (en) * 1997-12-09 2003-12-25 Hedlund Bo E. Modified polysaccharides exhibiting altered biological recognition
US6780852B2 (en) 1997-12-09 2004-08-24 Bo E. Hedlund Modified polysaccharides exhibiting altered biological recognition
EP1037642B9 (en) 1997-12-09 2010-10-13 Biomedical Frontiers, Inc. Modified polysaccharides exhibiting altered biological recognition
US7189703B2 (en) * 1998-01-09 2007-03-13 Intracell, Llc Treatment and diagnosis of alzheimer's disease
US6638711B1 (en) 1999-04-29 2003-10-28 The General Hospital Corporation Methods for identifying an agent that inhibits oxygen-dependent hydrogen peroxide formation activity but does not inhibit superoxide-dependent hydrogen peroxide formation
US20050112543A1 (en) * 1998-03-11 2005-05-26 The General Hospital Corporation Method of screening for drugs useful in treating Alzheimer's disease
US6946453B2 (en) 1998-11-18 2005-09-20 Collagenex Pharmaceuticals, Inc. 4-dedimethylaminotracycline derivatives
US6506740B1 (en) * 1998-11-18 2003-01-14 Robert A. Ashley 4-dedimethylaminotetracycline derivatives
DE10222561B4 (de) * 2002-05-17 2009-12-10 Dr. Franz Köhler Chemie GmbH Protektive Lösung zur Verhinderung von Ischämieschäden
US7728038B2 (en) * 2004-08-04 2010-06-01 University Of Utah Research Foundation Methods for chelation therapy
PL2977056T3 (pl) * 2014-07-11 2019-03-29 Grifols Worldwide Operations Limited Transferryna do zastosowania w leczeniu zaburzeń neurodegeneracyjnych związanych z czynnikiem indukowanym hipoksją (HIF)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1898E (fr) 1903-04-01 1903-11-07 Louis Galland Concasseur à machoires multiples
DE1123436B (de) 1959-09-25 1962-02-08 Ciba Geigy Verfahren zur Herstellung neuer Wuchsstoffe
NL270108A (it) 1960-10-11 1964-07-10
FR1315047A (fr) 1960-10-11 1963-01-18 Ciba Geigy Procédé de préparation d'acides trihydroxamiques à longue chaîne

Also Published As

Publication number Publication date
IT8249698A0 (it) 1982-12-20
US4419365A (en) 1983-12-06
DE3247062C2 (it) 1993-07-01
JPH0318602B2 (it) 1991-03-13
JPS58121213A (ja) 1983-07-19
DE3247062A1 (de) 1983-07-07
BE895406A (fr) 1983-06-20
ZA829335B (en) 1983-09-28

Similar Documents

Publication Publication Date Title
IT1155241B (it) Preparato farmaceutico contenente un sale di deferossammina per il trattamento di malattia di alzheimer
NL930112I1 (nl) Benzazepine-2-onen werkwijzen ter bereiding daarvan farmaceutische preparaten die deze verbindingen bevatten alsmede verbindingen voor de therapeutische toepassing
IT1210666B (it) Preparato farmaceutico ad assorbimento percutaneo per il trattamento di angina pectoris
IT1234215B (it) Forma di dosaggio per il trattamento di malattie cardiovascolari
IT8267184A0 (it) Bendaggio per la somministrazione di medicamenti
NO861331L (no) Fremgangsmaate for fremstilling av et hyaluronsyresalt.
NO822556L (no) Fremgangsmaate for fremstilling av inhaleringslegemidler
IT8248659A0 (it) Impiego di desferriossammina per il trattamento di affezioni artritiche
PT86986A (pt) Substituted 9-amino-tetrahydroacridines and related compounds a process for their preparation and their use as medicaments
IT1194748B (it) Composizioni farmaceutiche per il trattamento di osteopatie
FI823336L (fi) Foerfarande foer framstaellning av farmaceutiskt aktiva benzamidderivat
NO820581L (no) Maskin for fremstilling av kullsyreholdig drikke
PT87243A (pt) Process for the preparation of aliphatic carboxamides and of pharmaceutical compounds containing them
IT8448983A0 (it) Agente attivo farmaceutico per il trattamento di patologie cerebrali a base di uridina
FI824098A0 (fi) Terapeutiskt medel
PT88681A (pt) A process for the preparation of pharmaceutical compositions containing piperidinoalkanol derivatives
IT1210935B (it) Composizione farmaceutica per il trattamento di malattie cardiovascolari.
JPS57114508A (en) Pharmaceutical medicine for use of choline- action suppressive drug
FI822199L (fi) Substituerade imidazo(1,5-a)pyridiner, foerfarande foer deras framstaellning, dessa innehaollande farmaceutiska preparat, samt deras anvaendning
PT87079A (pt) Process for the preparation of dopamine-beta-hydroxylase inhibitors and of pharmaceutical compounds containing them
PT87572A (pt) Process for the preparation of pyrazines amino-methyl-phenolicsand of pharmaceutical compounds containing them
PT75626A (de) Aminooxazolylverbindungen verfahren zu ihrer herstellung pharmazeutische praeparate welche diese verbindungen enthalten
IT1154276B (it) Composti piridinici per il trattamento di cardiopatie coronariche
GB2092442B (en) Pharmaceutical composition for treating diseases of the oral cavity containing glycyrrhetinic acid or a derivative thereof
GB2092571B (en) Process for the synthesis of 3-keto-cyclopentene-5-oxy derivatives having insecticide activity

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19941118